Unravelling New Mechanisms in Itch From Targeting Type 2 Inflammation
Time: 9:00 am
day: Day One
Details:
- Understanding shared and unique characteristics of AD, PN and CSU
- How type 2 inflammation contributes to neuroimmune dysregulation
- Potential for IL-4Ra antagonism to reduce itch in chronic inflammatory skin diseases.
